Home Biosimilar Antibodies Others Others antibody Labetuzumab (Anti-CEACAM5 / CEA / CD66e) For research use only.
Not for use in humans.

Labetuzumab (Anti-CEACAM5 / CEA / CD66e)

Synonyms:

Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.

Labetuzumab (Anti-CEACAM5 / CEA / CD66e)

Purity & Quality Control

Batch: A263801 Purity: 99% Protein concentration: 3.25mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Labetuzumab (Anti-CEACAM5 / CEA / CD66e) is a humanised monoclonal antibody targeting carcinoembryonic antigen (CEA). It inhibits tumour growth and sensitises human medullary thyroid cancer xenografts to Dacarbazine chemotherapy. MW :145.36 KD.

Product Details

CAS No. 219649-07-7
Molecular Weight 145.36
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Labetuzumab (Anti-CEACAM5 / CEA / CD66e) | Labetuzumab (Anti-CEACAM5 / CEA / CD66e) supplier | purchase Labetuzumab (Anti-CEACAM5 / CEA / CD66e) | Labetuzumab (Anti-CEACAM5 / CEA / CD66e) cost | Labetuzumab (Anti-CEACAM5 / CEA / CD66e) manufacturer | order Labetuzumab (Anti-CEACAM5 / CEA / CD66e) | Labetuzumab (Anti-CEACAM5 / CEA / CD66e) distributor